Free Trial
TSE:RVX

Resverlogix (RVX) Stock Price, News & Analysis

Resverlogix logo
C$0.06 +0.01 (+22.22%)
As of 12:32 PM Eastern

About Resverlogix Stock (TSE:RVX)

Key Stats

Today's Range
C$0.05
C$0.06
50-Day Range
C$0.04
C$0.05
52-Week Range
C$0.04
C$0.10
Volume
100,166 shs
Average Volume
68,866 shs
Market Capitalization
C$10.89 million
P/E Ratio
N/A
Dividend Yield
7.02%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resverlogix and its competitors with MarketBeat's FREE daily newsletter.

RVX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
Resverlogix Corp. (RVXCF)
See More Headlines

RVX Stock Analysis - Frequently Asked Questions

Resverlogix's stock was trading at C$0.06 at the start of the year. Since then, RVX stock has increased by 0.0% and is now trading at C$0.06.

Resverlogix Corp. (TSE:RVX) posted its earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter.

Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Resverlogix investors own include ProMetic Life Sciences (PLI), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), Oncolytics Biotech (ONC), Radient Technologies (RTI), VentriPoint Diagnostics (VPT) and Burcon NutraScience (BU).

Company Calendar

Last Earnings
11/12/2024
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:RVX
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.81 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
6.06%
Return on Assets
-34.90%

Debt

Debt-to-Equity Ratio
-10.95
Current Ratio
0.13
Quick Ratio
0.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
132.50
Book Value
C($0.23) per share
Price / Book
-0.21

Miscellaneous

Outstanding Shares
197,937,403
Free Float
N/A
Market Cap
C$9.90 million
Optionable
Not Optionable
Beta
0.71
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (TSE:RVX) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners